GENE THERAPY FOR THE MASSES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 3/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed October 27, 2026
Protect or track "GENE THERAPY FOR THE MASSES"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is GENE THERAPY FOR THE MASSES filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99375244 | GENE THERAPY FOR THE MASSES | Sep 04, 2025 | Registered | 005 Pharmaceuticals 042 Science & Technology | Pacira Therapeutics, Inc. |
Weekly visibility reports showing how ChatGPT mentions GENE THERAPY FOR THE MASSES, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: GENE THERAPY FOR THE MASSES trademark portfolio
What trademarks does GENE THERAPY FOR THE MASSES hold?
GENE THERAPY FOR THE MASSES holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals), Class 42 (Science & Technology). The most recent filings are registered to Pacira Therapeutics, Inc..
How many trademarks does GENE THERAPY FOR THE MASSES have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to GENE THERAPY FOR THE MASSES. The brand has been actively filing since September 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does GENE THERAPY FOR THE MASSES file most often?
GENE THERAPY FOR THE MASSES's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the GENE THERAPY FOR THE MASSES trademark?
The most recent filings under the GENE THERAPY FOR THE MASSES mark are registered to Pacira Therapeutics, Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is GENE THERAPY FOR THE MASSES expanding into new categories?
The current WikiTrademarks Expansion Score for GENE THERAPY FOR THE MASSES is 3 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new GENE THERAPY FOR THE MASSES trademark filings?
Click the Watch Brand button at the top of this page to add GENE THERAPY FOR THE MASSES to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare GENE THERAPY FOR THE MASSES to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about GENE THERAPY FOR THE MASSES and help the next person researching it.